We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Submissions and Approvals » Regenerative Medicine: Steps to Accelerate Development

Other Options

PDF Edition

$397.00

PDF Edition - 3-4 Copies (10% Off)

$357.00

PDF Edition - 5-6 Copies (15% Off)

$337.00

PDF Edition - 7-9 Copies (20% Off)

$317.00

PDF Edition - 10+ Copies (25% Off)

$297.00

Regenerative Medicine: Steps to Accelerate Development

$397.00
Submissions and Approvals

Product Details

Regenerative Medicine
Steps to Accelerate Development

With the 21st Century Cures Act, attention is being focused on the use of human cells and tissue to treat serious and underserved conditions.

The FDA created a new regulatory paradigm in November 2017 when it issued four guidances — 2 final and 2 draft — aimed at explaining, streamlining and accelerating development of regenerative therapies.

Key among these developments is the creation of a new Regenerative Medicine Advanced Therapy (RMAT) designation that offers applicants an abbreviated pathway to approval, working closely with the FDA throughout the process.

Regenerative Medicine outlines the RMAT pathway and breaks down requirements regenerative medicine developers must meet to qualify. The FDA granted RMAT designation to 12 organizations in 2017 — the first year of the program. Now is the time to get in the mix, work with the FDA to develop the program and improve your chance of being one of the next RMAT designees.

You will learn:

  • Key definitions the FDA uses in evaluating regenerative medicine applications
  • Requirements to be eligible for RMAT designation
  • How to apply for RMAT designation
  • How the final versions of the Same Surgical Procedure and Minimal Manipulation guidances differ from their drafts

Order your copy of Regenerative Medicine: Steps to Accelerate Development and learn what it takes to get in on the ground floor of the new approval pathway and use it to accelerate your road to market.

Order Your Copy Today

PDF Edition

 

Available Format

PDF Edition — $397

Who Will Benefit

  • Regulatory affairs
  • Quality control
  • Legal professional
  • Business affairs professionals

Multi-user Access

Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.

Our Guarantee

Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing